FindTrial
Sign In

Campath 1H

DRUG11 trials

Sponsors

Baylor College of Medicine, Masonic Cancer Center, University of Minnesota, Northwestern University, National Institute of Allergy and Infectious Diseases (NIAID), Tami D. John

Conditions

Aplastic AnemiaChediak-Higashi SyndromeChronic Myeloproliferative DisordersDyskeratosis CongenitaFANCONI ANEMIAGraft FailureGriscelli SyndromeHematologic Malignancies

Early Phase 1

Donor Stem Cell Transplantation for Congenital Immunodeficiencies
CompletedNCT00426517
National Institute of Allergy and Infectious Diseases (NIAID)Inherited Immune Deficiencies
Start: 2007-01-19End: 2019-11-01Updated: 2021-05-11

Phase 1

Stem Cell Transplant for Patients With Blood Malignancy Using Donors and Less Toxic Chemotherapy With CAMPATH 1H
CompletedNCT00048412
Baylor College of MedicineLeukemia, Lymphoproliferative Disorders, Multiple Myeloma +2
Start: 2000-06-30End: 2004-11-12Target: 40Updated: 2020-01-18
Stem Cell Transplantation for Patients With Graft Failure Following an Allogeneic Transplant, Using Identical or Near Identical Donors and Less Toxic Conditioning With CAMPATH 1H
TerminatedNCT00048399
Baylor College of MedicineGraft Failure
Start: 2000-12-31End: 2003-10-31Target: 40Updated: 2020-01-18
Stem Cell Transplant for Hematologic Diseases
TerminatedNCT00058825
Baylor College of MedicineHematologic Malignancies
Start: 2000-08-31End: 2014-09-30Updated: 2016-11-07
Rheumatoid Arthritis:Tolerance Induction by Mixed Chimerism
TerminatedNCT00282412
Northwestern UniversityRheumatoid Arthritis
Start: 2002-09-30End: 2016-06-30Updated: 2018-07-30
Use of Rft5-Dga to Deplete Alloreactive Cells for Pts With Fanconi Anemia After Haploidentical SCT
TerminatedNCT00586274
Baylor College of MedicineFANCONI ANEMIA
Start: 2002-03-31End: 2009-07-31Updated: 2014-03-04

Phase 2

Total-Body Irradiation, Fludarabine, and Alemtuzumab Followed By Stem Cell Transplant in Treating Patients With Myeloproliferative Disorder, MS, AML, or CML
TerminatedNCT00069992
Baylor College of MedicineChronic Myeloproliferative Disorders, Leukemia, Myelodysplastic Syndromes
Start: 2001-12-31End: 2007-04-30Updated: 2012-10-10
Stem Cell Transplant for Immunologic or Histiocytic Disorders
CompletedNCT00176865
Masonic Cancer Center, University of MinnesotaChediak-Higashi Syndrome, Griscelli Syndrome, Hemophagocytic Lymphohistiocytosis +3
Start: 2002-08-31End: 2014-08-31Updated: 2017-12-28
Stem Cell Transplant (SCT) for Dyskeratosis Congenita or SAA
CompletedNCT00455312
Masonic Cancer Center, University of MinnesotaAplastic Anemia, Dyskeratosis Congenita
Start: 2007-08-31End: 2016-06-30Updated: 2017-12-05

Unknown Phase

Bone Marrow Transplantation, Hemoglobinopathies, SCALLOP
TerminatedNCT00578344
Tami D. JohnHemoglobin SC, Sickle Cell Disease
Start: 2005-07-31End: 2012-07-31Updated: 2020-07-31
Allogeneic Stem Cell Transplantation, Severe Homzygous 0/+Thalassemia or Sever Variants of Beta 0/+ Thalassemia, THALLO
TerminatedNCT00578292
Baylor College of MedicineThalassemia
Start: 2004-02-29End: 2016-05-31Updated: 2020-05-01